BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33879681)

  • 1. Association between NEAT1 polymorphism and the risk of lung cancer: A protocol for systematic review and meta-analysis.
    Hu Z; Chen J; Meng P; Li M
    Medicine (Baltimore); 2021 Apr; 100(16):e25478. PubMed ID: 33879681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between genetic polymorphisms of long noncoding RNA H19 and cancer risk: a meta-analysis.
    Hashemi M; Moazeni-Roodi A; Sarabandi S; Karami S; Ghavami S
    J Genet; 2019 Sep; 98():. PubMed ID: 31544800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NEAT1 polymorphisms and lung cancer susceptibility in a Chinese Northeast Han Population: A case-control study.
    Wang S; Cui Z; Li H; Li J; Lv X; Yang Z; Gao M; Bi Y; Zhang Z; Zhou B; Yin Z
    Pathol Res Pract; 2019 Dec; 215(12):152723. PubMed ID: 31704150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between long non-coding RNA polymorphism and the risk of coronary artery disease: A protocol for systematic review and meta-analysis.
    Wang B; Su Z; Wan L; He T
    Medicine (Baltimore); 2021 Mar; 100(12):e25146. PubMed ID: 33761682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between interleukin-8 gene-251 A/T polymorphism and sepsis: A protocol for systematic review and meta analysis.
    Zhao S; Gong J; Yin S; Li X; Zhao S; Mou T; Luo S
    Medicine (Baltimore); 2021 Apr; 100(15):e25483. PubMed ID: 33847655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between CYP2A13 polymorphisms and lung cancer: A protocol for systematic review and meta-analysis.
    Ma L; Jin G; Yang Y; Pang Y; Wang W; Zhang H; Liu J; Wu P; Wang Z; Wang K; Chang R; Li J; Zhu Z
    Medicine (Baltimore); 2020 Dec; 99(50):e23289. PubMed ID: 33327254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA HOTAIR polymorphism and susceptibility to cancer: an updated meta-analysis.
    Li J; Cui Z; Li H; Lv X; Gao M; Yang Z; Bi Y; Zhou B; Yin Z
    Environ Health Prev Med; 2018 Feb; 23(1):8. PubMed ID: 29463216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association between
    Moazeni-Roodi A; Aftabi S; Sarabandi S; Karami S; Hashemi M; Ghavami S
    J Genet; 2020; 99():. PubMed ID: 32661201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of lncRNA H19 polymorphisms and cancer risk: a meta-analysis based on 48,166 subjects.
    Liu X; Zhao Y; Li Y; Zhang J
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):15-27. PubMed ID: 31852249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between HOTAIR genetic polymorphisms and cancer susceptibility: A meta-analysis involving 122,832 subjects.
    Liu X; Zhao Y; Li Y; Lin F; Zhang J
    Genomics; 2020 Sep; 112(5):3036-3055. PubMed ID: 32454167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between thrombomodulin gene polymorphism and susceptibility to venous thromboembolism: A protocol for systematic review and meta-analysis.
    Wei M; Xue X; Pan Y; Wu Y
    Medicine (Baltimore); 2021 Mar; 100(11):e25001. PubMed ID: 33725974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of miR-155 and MIR155HG polymorphisms with cancer risk: A meta-analysis.
    Zou Z; Lu H; Zhang W; Li Y; He Y; Lin H; Zhao W; Yu D; Zeng B
    J Cancer Res Ther; 2021 Nov; 17(5):1209-1218. PubMed ID: 34850769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis.
    Qi L; Liu F; Zhang F; Zhang S; Lv L; Bi Y; Yu Y
    Biomed Pharmacother; 2018 Jul; 103():1507-1515. PubMed ID: 29864936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Association between miR-605 rs2043556 Polymorphism and Overall Cancer Risk: A Meta-analysis of Case-control Studies.
    Moazeni-Roodi A; Ghavami S; Hashemi M
    Microrna; 2019; 8(2):94-100. PubMed ID: 30514199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of HLA-B-associated transcript 3 polymorphisms on lung cancer risk: a meta-analysis.
    Zhao J; Wang H; Hu W; Jin Y
    Med Sci Monit; 2014 Nov; 20():2461-5. PubMed ID: 25430685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis.
    Sargazi S; Abghari AZ; Sarani H; Sheervalilou R; Mirinejad S; Saravani R; Eskandari E
    Appl Biochem Biotechnol; 2021 Dec; 193(12):4172-4196. PubMed ID: 34463927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEAT1 is a potential prognostic biomarker for patients with nasopharyngeal carcinoma.
    Liu Z; Wu K; Wu J; Tian D; Chen Y; Yang Z; Wu A
    J Cell Biochem; 2019 Jun; 120(6):9831-9838. PubMed ID: 30618186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1.
    You J; Zhang Y; Liu B; Li Y; Fang N; Zu L; Li X; Zhou Q
    Indian J Cancer; 2014 Mar; 51 Suppl 3():e77-81. PubMed ID: 25818739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in non-coding RNAs and risk of colorectal cancer: A systematic review and meta-analysis.
    Alidoust M; Hamzehzadeh L; Rivandi M; Pasdar A
    Crit Rev Oncol Hematol; 2018 Dec; 132():100-110. PubMed ID: 30447914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NEAT1 Promotes the Malignant Progression of Colorectal Cancer by Targeting ZEB1 via miR-448.
    Wu H; Dong D; Wang J; Yin S; Gong Y; Yang C; Bai Y; Wang J; Du Y
    Technol Cancer Res Treat; 2022; 21():15330338221085348. PubMed ID: 35695254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.